UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported)
 
April 2, 2020
 
AEHR TEST SYSTEMS
(Exact name of registrant as specified in its charter)
 
California
 
000-22893
 
94-2424084
(State or other jurisdiction of incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)
 
400 KATO TERRACE, FREMONT, CA 94539
(Address of principal executive offices, including zip code)
 
510-623-9400
(Registrant’s telephone number, including area code)
 
 N/A
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading
Name of each exchange on which registered
 
Symbol(s)
 
Common Stock
AEHR
The NASDAQ Capital Market
 

 
 
 
Item 2.02. Results of Operations and Financial Condition.
 
On April 2, 2020, Aehr Test Systems, or the Company, issued a press release announcing the Company’s financial results for its third quarter of fiscal year 2020 ended February 29, 2020. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
 
The information in this Form 8-K, including the exhibit attached hereto, are being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, as amended, or the Exchange Act, or otherwise subject to the liabilities of that Section, or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
 
Item 9.01. Financial Statements and Exhibits.
 
(d) Exhibits.
 
 
Exhibit No.
 
Description
 
Press Release of Aehr Test Systems dated April 2, 2020 entitled “Aehr Test Systems Reports 93% Revenue Growth Year over Year in Third Quarter. Withdraws Previously Provided Fiscal 2020 Financial Guideance Due to COVID-19 Uncertainty.”

 
 
 
 
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
Aehr Test Systems
(Registrant) 
 
 
 
 
 
Date: April 2, 2020
By:  
/s/  Kenneth B. Spink
 
 
 
Kenneth B. Spink
 
 
 
Vice President of Finance and  Chief Financial Officer
 
 
                                                                                                
 
aehr_ex991

 
 
Exhibit 99.1
 
 
FOR IMMEDIATE RELEASE
 
Contacts:
 
Aehr Test Systems
MKR Investor Relations Inc.
Ken Spink
Todd Kehrli or Jim Byers
Chief Financial Officer
Analyst/Investor Contact
(510) 623-9400 x309
(323) 468-2300
 
aehr@mkr-group.com

Aehr Test Systems Reports 93% Revenue Growth Year over Year in Third Quarter
 
Withdraws Previously Provided Fiscal 2020 Financial Guidance Due to COVID-19 Uncertainty
 
Fremont, CA (April 2, 2020) – Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and reliability qualification equipment, today announced financial results for its third quarter of fiscal 2020 ended February 29, 2020.
 
Fiscal Third Quarter Financial Results:
 
Net sales were $6.1 million, up 93% from $3.2 million in the third quarter of fiscal 2019.
GAAP net income was $245,000, or $0.01 per diluted share, compared to a GAAP net loss of $3.2 million, or $0.14 per diluted share, in the third quarter of fiscal 2019.
Non-GAAP net income was $452,000, or $0.02 per diluted share, which excludes the impact of stock-based compensation expense, compared to a non-GAAP net loss of $1.6 million, or $0.07 per diluted share, in the third quarter of fiscal 2019, which excluded stocked based compensation expense, a $795,000 provision for excess and obsolescence inventory, and $607,000 for restructuring charges related to a reduction in work force.
Backlog as of February 29, 2020 was $3.6 million.
 
Fiscal First Nine Months Financial Results:
 
Net sales were $18.5 million, up 34% from $13.8 million in the first nine months of fiscal 2019.
GAAP net income was $83,000, or $0.00 per diluted share, compared to a GAAP net loss of $5.3 million, or $0.24 per diluted share, in the first nine months of fiscal 2019.
Non-GAAP net income was $694,000, or $0.03 per diluted share, compared to a non-GAAP net loss of $3.2 million, or $0.15 per diluted share, in the first nine months of fiscal 2019.
 
An explanation of the use of non-GAAP financial information and a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in the accompanying tables.
 
 
 
 
Aehr Test Systems Reports Third Quarter Fiscal 2020 Financial Results
April 2, 2020
Page 2 of 6
   
Aehr Third Quarter and Recent Business Highlights:
 
Shipments for WaferPakTM Contactors and DiePakTM Carriers, consumables for Aehr’s FOXTM wafer and singulated die/module test and burn in systems, accounted for 51% of total revenue for the third quarter.
Shipped and reported revenue for an additional FOX-XP multi-wafer test and burn-in system to meet the production ramp of a leading supplier of silicon photonics devices.
Received orders totaling more than $2.9 million from its installed base of FOX test and burn-in system customers for its proprietary WaferPaks and DiePaks, including orders for test of mobile sensors and other device applications that include production test of silicon carbide devices, flash memories, and silicon photonics devices reflecting additional capacity needs.
Engaged with more than a dozen potential new customers for production level test and burn-in of devices that include power silicon carbide devices for automotive, silicon photonics devices for 5G and data storage server farms, automotive and mobile sensors, and memory devices.
As a global supplier to Critical Infrastructure as outlined at https://www.cisa.gov/identifying-critical-infrastructure-during-covid-19, Aehr is taking extraordinary measures to safely operate with our full capacity available in manufacturing and across the company to continue to support the vital needs of these Critical Infrastructure customers while complying with the local and state mandated “Shelter in Place” directives.
 
Gayn Erickson, President and CEO of Aehr Test Systems, commented:
 
“We are pleased with our results for the fiscal third quarter, which include continued profitability and strong gross margins. Despite the current challenging global environment, we continue to engage with a large number of customers who are evaluating the use of our products to meet their production needs in test and burn-in on a variety of applications. We are currently working with over a dozen new potential customers, and our sales, marketing, and applications teams remain busy supporting these sales efforts using online conferences, videos, and other collaboration tools.
 
“Currently, all of our customers have their wafer fabrication facilities open to support the critical infrastructure around the globe in information technology, communications, and critical manufacturing sectors and Aehr is able to ship orders for systems, WaferPaks, DiePaks, and parts needed to support these customers with little to no limitations or delays. However, due to the uncertainty of the full impact of the COVID-19 pandemic on our customers, we simply cannot predict how this will impact our business in the near term and are taking the conservative stance to withdraw our previously provided guidance for the fiscal 2020 year ending May 31, 2020.
 
“As the rapidly evolving COVID-19 pandemic unfolds, our foremost concern is to ensure the health and safety of our employees, their families, and our worldwide community. On March 19, 2020, the Executive Department of the State of California issued Executive Order N-33-20 ordering individuals in the State of California to stay home or at their place of residence except as needed to maintain continuity of operations of the federal Critical Infrastructure sectors. As a global supplier to Critical Infrastructure, we are taking extraordinary measures to maintain continuity of operations and to continue to safely operate with our full capacity available in manufacturing and across the company to support the vital needs of our Critical Infrastructure customers while complying with the local and state mandated “Shelter in Place” directives. Through direct and indirect representatives, Aehr also has engineers and infrastructure around the world to support our customers and meet our contracts, response times, and critical parts lead times for their installed base of Aehr Test products.
 
“The fundamentals for Aehr Test remain strong long term, and we believe that we will emerge from this difficult period even stronger than we went in, with an even larger number of customers committed to using our FOX systems to meet their production test and burn-in needs.”
 
 
 
 
Aehr Test Systems Reports Third Quarter Fiscal 2020 Financial Results
April 2, 2020
Page 3 of 6
 
Management Conference Call and Webcast
Aehr Test Systems will host a conference call and webcast today at 5:00 p.m. Eastern (2:00 p.m. PT) to discuss its third quarter fiscal 2020 operating results. To access the call dial 800-367-2403 (+1 334-777-6978 outside the United States) and give the participant pass code 2336638. In addition, a live and archived webcast of the conference call will be available over the Internet at www.aehr.com in the Investor Relations section. A replay of the conference call will also be available via telephone beginning approximately two hours after conclusion of the call through 8:00 p.m. ET on April 9, 2020. To access the replay dial-in information, please click here.
 
About Aehr Test Systems
Headquartered in Fremont, California, Aehr Test Systems is a worldwide provider of test systems for burning-in and testing logic, optical and memory integrated circuits and has installed over 2,500 systems worldwide. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets are driving additional test requirements, incremental capacity needs, and new opportunities for Aehr Test products in package, wafer level, and singulated die/module level test. Aehr Test has developed and introduced several innovative products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak Loader. The ABTS system is used in production and qualification testing of packaged parts for both lower power and higher power logic devices as well as all common types of memory devices. The FOX-XP and FOX-NP systems are full wafer contact and singulated die/module test and burn-in systems used for burn-in and functional test of complex devices, such as leading-edge memories, digital signal processors, microprocessors, microcontrollers, systems-on-a-chip, and integrated optical devices. The FOX-CP system is a new low-cost single-wafer compact test and reliability verification solution for logic, memory and photonic devices and the newest addition to the FOX-P product family. The WaferPak contactor contains a unique full wafer probecard capable of testing wafers up to 300mm that enables IC manufacturers to perform test and burn-in of full wafers on Aehr Test FOX systems. The DiePak Carrier is a reusable, temporary package that enables IC manufacturers to perform cost-effective final test and burn-in of both bare die and modules. For more information, please visit Aehr Test Systems’ website at www.aehr.com.
 
Safe Harbor Statement
This press release contains certain forward-looking statements based on current expectations, forecasts and assumptions that involve risks and uncertainties. These statements are based on information available to Aehr as of the date hereof and actual results could differ materially from those stated or implied due to risks and uncertainties. Forward-looking statements include statements regarding Aehr’s expectations, beliefs, intentions or strategies regarding its products and financial guidance, including statements regarding future market opportunities and conditions, the impact of COVID-19 and related shelter in place orders and economic effects on production and demand for Aehr’s products, expected product shipment dates, customer orders or commitments and future operating results. These risks and uncertainties include, without limitation, customer demand and acceptance of Aehr’s products, the ability of new products to meet customer needs or perform as described, as well as general market conditions, the deployment of new technologies, such as 5G networks, and Aehr’s ability to execute on its business strategy. See Aehr’s recent 10-K, 10-Q and other reports from time to time filed with the Securities and Exchange Commission for a more detailed description of the risks facing Aehr’s business. Aehr disclaims any obligation to update information contained in any forward-looking statement to reflect events or circumstances occurring after the date of this press release.
 
– Financial Tables to Follow –
 
 
 
 
Aehr Test Systems Reports Third Quarter Fiscal 2020 Financial Results
 
 
April 2, 2020
 
 
 
Page 4 of 6
 
 
 
 
 
AEHR TEST SYSTEMS AND SUBSIDIARIES
 
 
Condensed Consolidated Statements of Operations
 
 
(in thousands, except per share data)
 
 
(unaudited)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    Three Months Ended    
 
 
  Nine Months Ended  
 
 
 
Feb 29,
 
 
Nov 30,
 
 
Feb 28,
 
 
Feb 29,
 
 
Feb 28,
 
 
 
2020
 
 
2019
 
 
2019
 
 
2020
 
 
2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net sales
 $6,111 
 $6,874 
 $3,163 
 $18,518 
 $13,814 
Cost of sales
  3,120 
  3,672 
  2,891 
  10,054 
  9,591 
Gross profit
  2,991 
  3,202 
  272 
  8,464 
  4,223 
 
    
    
    
    
    
Operating expenses:
    
    
    
    
    
  Selling, general and administrative
  1,891 
  2,157 
  1,850 
  5,856 
  5,706 
  Research and development
  845 
  795 
  931 
  2,532 
  3,033 
  Restructuring
  - 
  - 
  607 
  - 
  607 
      Total operating expenses
  2,736 
  2,952 
  3,388 
  8,388 
  9,346 
 
    
    
    
    
    
      Income (loss) from operations
  255 
  250 
  (3,116)
  76 
  (5,123)
 
    
    
    
    
    
Interest income (expense), net
  13 
  2 
  (76)
  27 
  (228)
Other (expense) income, net
  (9)
  5 
  (11)
  6 
  27 
 
    
    
    
    
    
       Income (loss) before income tax (expense) benefit
  259 
  257 
  (3,203)
  109 
  (5,324)
 
    
    
    
    
    
Income tax (expense) benefit
  (14)
  (6)
  2 
  (26)
  (21)
 
    
    
    
    
    
       Net income (loss)
  245 
  251 
  (3,201)
  83 
  (5,345)
 
    
    
    
    
    
Less: Net income attributable to the
    
    
    
    
    
     noncontrolling interest
  - 
  - 
  - 
  - 
  - 
 
    
    
    
    
    
       Net income (loss) attributable to Aehr Test
    
    
    
    
    
     Systems common shareholders
 $245 
 $251 
 $(3,201)
 $83 
 $(5,345)
 
    
    
    
    
    
Net income (loss) per share
    
    
    
    
    
        Basic
 $0.01 
 $0.01 
 $(0.14)
 $0.00 
 $(0.24)
        Diluted
 $0.01 
 $0.01 
 $(0.14)
 $0.00 
 $(0.24)
 
    
    
    
    
    
Shares used in per share calculations:
    
    
    
    
    
        Basic
  22,937 
  22,823 
  22,459 
  22,823 
  22,314 
        Diluted
  23,130 
  22,912 
  22,459 
  22,940 
  22,314 
 
    
    
    
    
    
 
    
    
    
    
    
 
-more-
 
 
  
 
 
 
Aehr Test Systems Reports Third Quarter Fiscal 2020 Financial Results
 
 
April 2, 2020
 
 
 
Page 5 of 6
 
 
 
 
 
 
AEHR TEST SYSTEMS AND SUBSIDIARIES
 
 
Reconciliation of GAAP and Non-GAAP Results
 
 
(in thousands, except per share data)
 
 
(unaudited)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended
 
 
Nine Months Ended
 
 
 
Feb 29,
 
 
Nov 30,
 
 
Feb 28,
 
 
Feb 29,
 
 
Feb 28,
 
 
 
2020
 
 
2019
 
 
2019
 
 
2020
 
 
2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GAAP net income (loss)
 $245 
 $251 
 $(3,201)
 $83 
 $(5,345)
Stock-based compensation expense
  207 
  205 
  225 
  611 
  705 
Restructuring
  - 
  - 
  607 
  - 
  607 
Excess and obsolescence provision
  - 
  - 
  795 
  - 
  795 
Non-GAAP net income (loss)
 $452 
 $456 
 $(1,574)
 $694 
 $(3,238)
 
    
    
    
    
    
GAAP net income (loss) per diluted share
 $0.01 
 $0.01 
 $(0.14)
 $0.00 
 $(0.24)
Non-GAAP net income (loss) per diluted share
 $0.02 
 $0.02 
 $(0.07)
 $0.03 
 $(0.15)
Shares used in GAAP diluted shares calculation
  23,130 
  22,912 
  22,459 
  22,940 
  22,314 
Shares used in non-GAAP diluted shares calculation
  23,130 
  22,912 
  22,459 
  22,940 
  22,314 
            
 
 
 
 
 
 
 
 
 
 
 
 
Non-GAAP net income (loss) is a non-GAAP measure and should not be considered a replacement for GAAP results. Non-GAAP net income (loss) is a financial measure the Company uses to evaluate the underlying results and operating performance of the business. The limitation of this measure is that it excludes items that impact the Company's current period net income. This limitation is best addressed by using this measure in combination with net income (loss) (the most directly comparable GAAP financial measure). These measures are not in accordance with GAAP and may differ from non-GAAP methods of accounting and reporting used by other companies.
 
We believe these measures enhance investors’ ability to review the company’s business from the same perspective as the company’s management and facilitate comparisons of this period’s results with prior periods.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-more-

 
 
 
 
Aehr Test Systems Reports Third Quarter Fiscal 2020 Financial Results
 
 
April 2, 2020
 
 
 
Page 6 of 6
 
 
 
 
 
AEHR TEST SYSTEMS AND SUBSIDIARIES
 
 
Condensed Consolidated Balance Sheets
 
 
(in thousands, except per share data)
 
 
(unaudited)
 
 
 
 
 
 
 
 
 
 
 
 
 
February 29,
 
 
November 30,
 
 
May 31,
 
 
 
2020
 
 
2019
 
 
2019
 
ASSETS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
  Cash and cash equivalents
 $5,058 
 $5,302 
 $5,428 
  Accounts receivable, net
  3,511 
  5,231 
  4,859 
  Inventories
  9,330 
  9,800 
  9,061 
  Prepaid expenses and other
  586 
  534 
  686 
      Total current assets
  18,485 
  20,867 
  20,034 
 
    
    
    
Property and equipment, net
  783 
  860 
  1,045 
Operating lease right-of-use assets
  2,260 
  2,387 
  - 
Other assets
  160 
  186 
  228 
      Total assets
 $21,688 
 $24,300 
 $21,307 
 
    
    
    
LIABILITIES AND SHAREHOLDERS' EQUITY
    
    
    
 
    
    
    
Current liabilities:
    
    
    
  Accounts payable
 $925 
 $2,320 
 $1,933 
  Accrued expenses
  1,373 
  1,596 
  2,034 
  Operating lease liabilities, short-term
  644 
  619 
  - 
  Customer deposits and deferred revenue, short-term
  385 
  1,809 
  1,545 
      Total current liabilities
  3,327 
  6,344 
  5,512 
 
    
    
    
Deferred rent
  - 
  - 
  153 
Operating lease liabilities, long-term
  1,772 
  1,924 
  - 
Deferred revenue, long-term
  34 
  64 
  189 
      Total liabilities
  5,133 
  8,332 
  5,854 
 
    
    
    
Aehr Test Systems shareholders' equity
  16,575 
  15,988 
  15,472 
Noncontrolling interest
  (20)
  (20)
  (19)
      Total shareholders' equity
  16,555 
  15,968 
  15,453 
 
    
    
    
      Total liabilities and shareholders' equity
 $21,688 
 $24,300 
 $21,307 
 
# # #